levalbuterol tartrate

FDA Drug Profile — Levalbuterol tartrate HFA inhalation, XOPENEX HFA

levalbuterol tartrate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including Levalbuterol tartrate HFA inhalation, XOPENEX HFA. Available dosage form: aerosol, metered.

Drug details

Generic Name
levalbuterol tartrate
Brand Names
Levalbuterol tartrate HFA inhalation, XOPENEX HFA
Application Number
NDA021730
Sponsor
Proficient Rx LP
NDC Codes
3
Dosage Forms
AEROSOL, METERED
Routes
ORAL
Active Ingredients
LEVALBUTEROL TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE XOPENEX HFA is a beta 2 -adrenergic agonist indicated for the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease. ( 1.1 ) 1.1 Bronchospasm XOPENEX HFA is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstructive airway disease.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.